Requests that the FDA: 1. Conduct or expedite the scientific and medical evaluation of psilocybin and MDMA under the eight factors in 21 U.S.C. S 811(c) and provide a scheduling recommendation to the Drug Enforcement Administration
🏛 Food and Drug Administration (FDA)FDA-2026-P-7014
Documents
2
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jun 24, 2026No comment period